An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
Referred to Health
Email me when HB 2181 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HB 2181. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill adds a definition of “opioid antagonist” to the state Controlled Substance Act, specifying that it includes FDA‑approved drugs like naloxone and nalmefene used to reverse opioid overdoses. The change clarifies the terminology for regulators, courts, and health officials. It takes effect 60 days after enactment.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HB 2181
3 free questions a day, no accountHistory
- Referred to Health
Sponsors
- Chris Pielli (D) · sponsor
- Benjamin Sanchez
- Brian Munroe
- Carol Hill-Evans
- Dan Williams
- G. Roni Green
- Jeanne Mcneill
- Jennifer O'Mara
- Johanny Cepeda-Freytiz
- Lisa Borowski
- Liz Hanbidge
- Mary Jo Daley
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HB 2181 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HB 2181 freeOr ask your AI assistant about HB 2181 directly:
Add to Claude, ChatGPT or Cursor